However, in cancer, they remain perpetually activated by a number of factors including the presence of cancer cells, as indicated by their expression of activation markers [e.g., α smooth muscle actin (αSMA), fibroblast activation protein (FAP)] and promote tumour progression via multiple pathways. This evidence concerns the gene ACTA1 and neoplasm.